New Two-year Guselkumab Data Show Patients With Moderate To Severe Plaque Psoriasis Achieved Consistent Rates Of Skin Clearance.
- EMEA Innovative Medicine
- New Two-year Guselkumab Data Show Patients With Moderate To Severe Plaque Psoriasis Achieved Consistent Rates Of Skin Clearance.
New Two-year Guselkumab Data Show Patients With Moderate To Severe Plaque Psoriasis Achieved Consistent Rates Of Skin Clearance.
- X (Twitter)
Copy link